[Ultrastructure of Rous sarcoma virus cultivated in vitro].

F. Haguenau,H. Febvre,J. Arnoult

1960-02-29

Comptes rendus hebdomadaires des séances de l Académie des sciences

Abstract:

What problem does this paper attempt to address?

Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition

Ke Yao,Qianxue Mou,Xiaotong Lou,Meng Ye,Bowen Zhao,Yuanyuan Hu,Jing Luo,Hong Zhang,Xing Li,Yin Zhao

DOI: https://doi.org/10.1186/s12974-023-02886-8

2023-09-05

Abstract:Background: Optic nerve injury (ONI) is a key cause of irreversible blindness and triggers retinal ganglion cells (RGCs) change and synapse loss. Microglia is the resistant immune cell in brain and retina and has been demonstrated to be highly related with neuron and synapse injury. However, the function of Sirtuin 1 (SIRT1), a neuroprotective molecule, in mediating microglial activation, retinal synapse loss and subsequent retinal ganglion cells death in optic nerve injury model as well as the regulatory mechanism remain unclear. Method: To this end, optic nerve crush (ONC) model was conducted to mimic optic nerve injury. Resveratrol and EX527, highly specific activator and inhibitor of SIRT1, respectively, were used to explore the function of SIRT1 in vivo and vitro. Cx3Cr1-CreERT2/RaptorF/F mice were used to delete Raptor for inhibiting mammalian target of rapamycin complex 1 (mTORC1) activity in microglia. HEK293 and BV2 cells were transfected with plasmids to explore the regulatory mechanism of SIRT1. Results: We discovered that microglial activation and synapse loss in retinal inner plexiform layer (IPL) occurred after optic nerve crush, with later-development retinal ganglion cells death. SIRT1 activation induced by resveratrol inhibited microglial activation and attenuated synapse loss and retinal ganglion cells injury. After injury, microglial phagocytosed synapse and SIRT1 inhibited this process to protect synapse and retinal ganglion cells. Moreover, SIRT1 exhibited neuron protective effects via activating tuberous sclerosis complex 2 (TSC2) through deacetylation, and enhancing the inhibition effect of tuberous sclerosis complex 2 on mammalian target of rapamycin complex 1 activity. Conclusion: Our research provides novel insights into microglial SIRT1 in optic nerve injury and suggests a potential strategy for neuroprotective treatment of optic nerve injury disease.
Detection of macroenzymes in serum by high-performance gel permeation chromatography.

J. Sion,M. Laureys,E. Gerlo,F. Gorus

DOI: https://doi.org/10.1016/S0378-4347(00)82555-4

IF: 4.601

Journal of Chromatography A

Abstract:
SIRT1 Protects Against Apoptosis by Promoting Autophagy in the Oxygen Glucose Deprivation/Reperfusion-Induced Injury.

Qiannan Ren,Zhiying Hu,Yuting Jiang,Xiaoning Tan,Benson O. A. Botchway,Nashwa Amin,Gaoping Lin,Yu Geng,Marong Fang

DOI: https://doi.org/10.3389/fneur.2019.01289

IF: 3.4

2019-01-01

Frontiers in Neurology

Abstract:Silent information regulator 1 (SIRT1) contributes to cellular regulation. Previous studies have reported SIRT1 to be abnormally expressed in the ischemic penumbra of cerebral ischemia/reperfusion (I/R) injury rat model. We investigated the effect of SIRT1 on oxygen and glucose deprivation/reperfusion (OGD/R) cell injury. Over-expressed or silenced SIRT1 pheochromocytoma 12 (PC12) cells were exposed to an in-vitro OGD/R injury. Western blot, TUNEL staining and immunofluorescence analyses were performed to assess apoptosis and autophagy. We found autophagy and apoptosis to be up-regulated and down-regulated, respectively, following the over-expression of SIRT1 in the OGD/R-induced PC12 cells. We also found the silencing of SIRT1 to culminate in the down-regulation and up-regulation of autophagy and apoptosis, respectively. On the basis of our results, we surmise that SIRT1 can promote autophagy and inhibit apoptosis in-vitro, and thus exhibit potential neuroprotection against OGD/R-induced injury. This could facilitate in the development of therapeutic approaches for cerebral I/R injury.
Modulation of Sirt1-mTORC1 Pathway in Microglia Attenuates Retinal Ganglion Cell Loss After Optic Nerve Injury

Qianxue Mou,Ke Yao,Meng Ye,Bowen Zhao,Yuanyuan Hu,Xiaotong Lou,Huixia Li,Hong Zhang,Yin Zhao

DOI: https://doi.org/10.2147/JIR.S338815

IF: 4.5

2021-12-14

Journal of Inflammation Research

Abstract:Qianxue Mou, 1 Ke Yao, 1 Meng Ye, 1 Bowen Zhao, 1 Yuanyuan Hu, 1 Xiaotong Lou, 1 Huixia Li, 2 Hong Zhang, 1 Yin Zhao 1 1 Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China; 2 Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, People's Republic of China Correspondence: Hong Zhang Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China Email Correspondence: Yin Zhao Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China Email Purpose: Optic nerve injury (ONI) causes neuroinflammation and neurodegeneration leading to visual deficits. The response of microglia has emerged as an impactful component of etiology in neurodegeneration. This study aimed to investigate the effect of SIRT1-mTORC1 signaling pathway in microglia regulation after ONI. Methods: Cx3Cr1-Cre ERT2 / Raptor F/F and Cx3Cr1-Cre ERT2 / Sirt1 F/F mice were used to delete Raptor and Sirt1 in microglia, respectively. Optic nerve crush (ONC) model was established to mimic ONI. PLX5622, a highly specific inhibitor of the colony-stimulating factor 1 receptor (CSF1R), is used to eliminate microglia in optic nerve. Ionized calcium binding adaptor molecule 1 (Iba1) immunostaining was used to detect microglial activation. Retinal ganglion cells (RGCs) were quantified by Nissl staining and retinal whole-mount immunostaining with RNA-binding protein with multiple splicing (RBPMS). Axonal damage was valued by transmission electron microscopy (TEM). Results: Microglial activation emerged on day 3 post ONC and was earlier than RGCs loss which occurred at day 5 after injury. Depleting microglia with PLX5622 could attenuate the loss of RGCs and axon damage after ONC. Gain- and loss-of-function studies revealed that SIRT1 determined the activation of microglia in optic nerve. In addition, microglia-specific deletion of Raptor resulted in decreased microglial activation. Interestingly, activating mTORC1 with CCT007093 could reverse the function of SIRT1 in regulating the process of microglial activation mediated RGCs loss. Conclusion: Our study reveals a potential novel mechanism of SIRT1-mTORC1 pathway in microglia regulation, and indicates a therapeutic potential for the protection of RGCs in ONI. Keywords: microglia, retinal ganglion cells, optic nerve injury, SIRT1, mTORC1 Diverse pathological states cause degeneration of axons leading to irreversible vision loss, including ocular hypertension, trauma and optic neuritis. 1,2 In these relative diseases, focal axon injury triggers a propagating axon loss and eventually neuronal death. 3 Therefore, axonal injury is thought to be the critical early event for RGCs loss. Multiple glial cell types participate in the process of axonal degeneration after optic nerve injury (ONI), including oligodendroglia, astroglia and microglia. 4–6 The microglia form a population of resident macrophages within the retina and optic nerve. 6,7 In healthy retina, microglia are of vital importance in maintain the normal structure and functioning of the retina. 8 Once activated by noxious insults, microglia can release inflammatory cytokines, such as TNF-α, IL-1β and reactive oxygen species, which could damage RGCs and promote neurodegeneration, and inappropriate phagocytosis by microglia can further accelerate RGCs loss. 9,10 A previous study has shown that microglial activation can aggravate trauma-induced RGCs degeneration, which leads to RGCs loss. 11 Thus, regulation of microglial activation enables microglia to function better as guardians during pathological processes. 12 Besides immune activity, the microglia also participate in the development and maintenance of neural networks, as well as in neurovascular unit homeostasis. 7,13,14 Noteworthy, genetic ablation and/or pharmacological blockade of microglia shows neuroprotective effect in neurodegenerative diseases. 15,16 Sirtuin 1 (SIRT1), a nicotinamide adenine dinucleotide (NAD)-dependent deacetylase, deacetylates transcription factors, signaling molecules, and histones. 17,18 Resveratrol enhances SIRT1 activity via promoting NADH oxidation to NAD+ and, possibly, by boosting SI -Abstract Truncated-

immunology
The Neuroprotective Effects of SIRT1 on NMDA-Induced Excitotoxicity

Xiaorong Yang,Peipei Si,Huaping Qin,Litian Yin,Liang-Jun Yan,Ce Zhang

DOI: https://doi.org/10.1155/2017/2823454

Abstract:Silent information regulator 1 (SIRT1), an NAD+-dependent deacetylase, is involved in the regulation of gene transcription, energy metabolism, and cellular aging and has become an important therapeutic target across a range of diseases. Recent research has demonstrated that SIRT1 possesses neuroprotective effects; however, it is unknown whether it protects neurons from NMDA-mediated neurotoxicity. In the present study, by activation of SIRT1 using resveratrol (RSV) in cultured cortical neurons or by overexpression of SIRT1 in SH-SY5Y cell, we aimed to evaluate the roles of SIRT1 in NMDA-induced excitotoxicity. Our results showed that RSV or overexpression of SIRT1 elicited inhibitory effects on NMDA-induced excitotoxicity including a decrease in cell viability, an increase in lactate dehydrogenase (LDH) release, and a decrease in the number of living cells as measured by CCK-8 assay, LDH test, and Calcein-AM and PI double staining. RSV or overexpression of SIRT1 significantly improved SIRT1 deacetylase activity in the excitotoxicity model. Further study suggests that overexpression of SIRT1 partly suppressed an NMDA-induced increase in p53 acetylation. These results indicate that SIRT1 activation by either RSV or overexpression of SIRT1 can exert neuroprotective effects partly by inhibiting p53 acetylation in NMDA-induced neurotoxicity.
Chronically low NMNAT2 expression causes sub-lethal SARM1 activation and altered response to nicotinamide riboside in axons

Christina Antoniou,Andrea Loreto,Jonathan Gilley,Elisa Merlini,Giuseppe Orsomando,Michael P Coleman

DOI: https://doi.org/10.1101/2024.03.14.584798

2024-03-14

Abstract:Nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) is an endogenous axon survival factor that maintains axon health by blocking activation of the downstream pro-degenerative protein SARM1 (sterile alpha and TIR motif containing protein 1). While complete absence of NMNAT2 in mice results in extensive axon truncation and perinatal lethality, the removal of SARM1 completely rescues these phenotypes. Reduced levels of NMNAT2 can be compatible with life, however they compromise axon development and survival. Mice born expressing sub-heterozygous levels of NMNAT2 remain overtly normal into old age but develop axonal defects and as well as behavioural phenotypes. Therefore, it is important to examine the effects of constitutively low NMNAT2 expression on SARM1 activation and disease susceptibility. Here we demonstrate that chronically low NMNAT2 levels reduce prenatal viability in mice in a SARM1-dependent manner and lead to sub-lethal SARM1 activation in morphologically intact axons of superior cervical ganglion (SCG) primary cultures. This is characterised by a depletion in NAD(P) and compromised neurite outgrowth. We also show that chronically low NMNAT2 expression reverses the NAD-enhancing effect of nicotinamide riboside (NR) in axons in a SARM1-dependent manner. These data indicate that low NMNAT2 levels can trigger sub-lethal SARM1 activation which is detectable at the molecular level and could predispose to human axonal disorders.

Neuroscience
[Type 1 neurofibromatosis in Tunisia: 66 cases].

R. Gouider,M. Azaiz,M. Kchouk,L. Lasram,A. Ben Osman,A. Mrabet

IF: 0.934

Annales de Dermatologie et de Vénéréologie

Abstract:A multidisciplinary transversal descriptive study was conducted from June to October 1992 to determine the clinical manifestations and laboratory findings observed in 66 patients with type 1 neurofibromatosis. Diagnostic criteria were those of the National Institute of Health as recommended for subjects over 20 years of age. All patients over the age of 25 had café au lait spots, neurofibromas, lentigines and nodules. Occurrence of lesions of the central nervous system was significantly earlier than peripheral nervous manifestations. The optic glioma was the most frequent lesion of the central nervous system. Complications were observed during the first twenty years of the disease. Based on these findings, we propose a clinical and laboratory work-up designed as a function of age.
Synthesis of racemic sirenin, a plant sex hormone.

K. Mori,M. Matsui

DOI: https://doi.org/10.1016/S0040-4039(01)88716-5

IF: 2.032

Tetrahedron Letters

Abstract:
Overexpression of Sirtuin 1 protein in neurons prevents and reverses experimental diabetic neuropathy.

Aaron Long,T. Kristian,J. Russell,Joungil Choi,M. Salimian,Nina Klimova,Sruthi R Konduru,Pranith Kumar,Cheng-Ying Ho,K. Chandrasekaran

DOI: https://doi.org/10.1093/brain/awz324

2019-11-21

Abstract:In diabetic neuropathy, there is activation of axonal and sensory neuronal degeneration pathways leading to distal axonopathy. The nicotinamide-adenine dinucleotide (NAD+)-dependent deacetylase enzyme, Sirtuin 1 (SIRT1), can prevent activation of these pathways and promote axonal regeneration. In this study, we tested whether increased expression of SIRT1 protein in sensory neurons prevents and reverses experimental diabetic neuropathy induced by a high fat diet (HFD). We generated a transgenic mouse that is inducible and overexpresses SIRT1 protein in neurons (nSIRT1OE Tg). Higher levels of SIRT1 protein were localized to cortical and hippocampal neuronal nuclei in the brain and in nuclei and cytoplasm of small to medium sized neurons in dorsal root ganglia. Wild-type and nSIRT1OE Tg mice were fed with either control diet (6.2% fat) or a HFD (36% fat) for 2 months. HFD-fed wild-type mice developed neuropathy as determined by abnormal motor and sensory nerve conduction velocity, mechanical allodynia, and loss of intraepidermal nerve fibres. In contrast, nSIRT1OE prevented a HFD-induced neuropathy despite the animals remaining hyperglycaemic. To test if nSIRT1OE would reverse HFD-induced neuropathy, nSIRT1OE was activated after mice developed peripheral neuropathy on a HFD. Two months after nSIRT1OE, we observed reversal of neuropathy and an increase in intraepidermal nerve fibre. Cultured adult dorsal root ganglion neurons from nSIRT1OE mice, maintained at high (30 mM) total glucose, showed higher basal and maximal respiratory capacity when compared to adult dorsal root ganglion neurons from wild-type mice. In dorsal root ganglion protein extracts from nSIRT1OE mice, the NAD+-consuming enzyme PARP1 was deactivated and the major deacetylated protein was identified to be an E3 protein ligase, NEDD4-1, a protein required for axonal growth, regeneration and proteostasis in neurodegenerative diseases. Our results indicate that nSIRT1OE prevents and reverses neuropathy. Increased mitochondrial respiratory capacity and NEDD4 activation was associated with increased axonal growth driven by neuronal overexpression of SIRT1. Therapies that regulate NAD+ and thereby target sirtuins may be beneficial in human diabetic sensory polyneuropathy.

Medicine,Biology,Chemistry
Modulation by SIRT1-mTORC1 Pathway Microglia Pruning Retinal Ganglion Cell Dendrites

Ke Yao,Qianxue Mou,Xiaotong Lou,Meng Ye,Bowen Zhao,Yuanyuan Hu,Jing Luo,Hong Zhang,Xing Li,Yin Zhao

DOI: https://doi.org/10.2139/ssrn.4097123

2022-01-01

Abstract:The engulfment of retinal ganglion cells (RGCs) dendrites by microglia plays a key role in maintaining retinal homeostasis. Here, we used conditional knockout mouse model and pharmacological agonists to investigate the molecular mechanism of microglia activation in response to optic nerve injury (ONI). We found that the RGCs excitatory synapse loss pruned by microglia is earlier than the soma loss in ONI models. SIRT1 can inhibit microglial activation to protect RGCs synapse loss from the injury. In vitro experiments showed that SIRT1 mediates deacetylation of TSC2 at lysine residues 1473, which decreases TSC2 phosphorylation at tyrosine 1462 and finally influences the activity of mTORC1 pathway. In vivo studies revealed that SIRT1-mTORC1 signal pathway is engaged in microglial activation and phagocytosis of RGCs dendrites. These findings suggest a novel mechanism of RGCs synaptic pruning by microglia, and may provide new insights into ONI disease progression and inform the development of novel therapies to prevent vision loss.
Oxygen–Glucose Deprivation/Reperfusion-Induced Sirt3 Reduction Facilitated Neuronal Injuries in an Apoptosis-Dependent Manner During Prolonged Reperfusion

Rongqi Wan,Jiahui Fan,Huimeng Song,Wei Sun,Yanling Yin

DOI: https://doi.org/10.1007/s11064-021-03502-y

IF: 4.4

2022-01-29

Neurochemical Research

Abstract:Cerebral ischemia is a major cause of morbidity and permanent disability. To date, no treatments for cerebral ischemia/reperfusion injury can be effectively administered beyond 4–6 h after the ischemic insult. Our study aimed to clarify the significance of Sirt3 during acute cerebral ischemia and explore Sirt3-targeted therapy for ischemic injuries. Upon establishing the oxygen–glucose deprivation/reperfusion (OGD/R) cell model, changes of Sirt3 protein levels and the effects of Sirt3 overexpression on primary hippocampal neurons were detected at indicated time points. Moreover, mitochondrial damage was observed in neurons upon OGD/R injury. The results showed that compared with the normoxia group, Sirt3 protein was significantly decreased in hippocampal neurons exposed to 1 h of OGD followed by 12 h of reperfusion. In addition, the reduction of Sirt3 protein levels contributed to OGD/R-induced neuronal injuries, a higher ratio of neuronal apoptosis, and extensive production of reactive oxygen species (ROS). However, all neuronal injuries were partly rescued by Sirt3 overexpression induced by lentivirus transfection. Mitochondrial morphologies were significantly impaired after OGD/R, but partly salvaged by Sirt3 overexpression. We further explored whether pharmacologically activating Sirt3 is protective for neurons, and found that treatment with honokiol (a Sirt3 agonist) after OGD exposure activated Sirt3 during reperfusion and significantly alleviated OGD/R-induced neuronal injuries. Because mitochondrial functions are essential for neuronal survival, the current results indicate that Sirt3 may be an efficient target to suppress ischemic injuries via maintenance of mitochondrial homeostasis. Our current findings shed light on a novel therapeutic strategy against subacute ischemic injuries.

biochemistry & molecular biology,neurosciences
Inhibition of Neural Stem Cell Necroptosis Mediated by RIPK1/MLKL Promotes Functional Recovery After SCI

Kuileung Tong,Shiming Li,Guoliang Chen,Chao Ma,Xizhe Liu,Shaoyu Liu,Ningning Chen

DOI: https://doi.org/10.1007/s12035-022-03156-z

IF: 5.682

2023-01-06

Molecular Neurobiology

Abstract:Endogenous neural stem cells (eNSCs) are a new therapeutic strategy for the noninvasive repair of spinal cord injury (SCI). Necroptosis is a necrosome-dependent cell death process that serves as a significant regulatory mechanism in SCI. Current research shows that neurons, oligodendrocytes, and astrocytes all undergo necroptosis after SCI. However, it is unclear whether eNSCs are associated with necroptosis after SCI. By performing immunofluorescence analysis, we found that eNSCs undergo necroptosis during spinal cord injury repair in mice. Our present work demonstrates that receptor-interacting protein kinase 1 (RIPK1)/mixed lineage kinase domain-like protein (MLKL) are involved in necroptosis pathway in SCI mice. In vitro, the necroptosis induced by TNF-α/Smac-mimetic/Z-VAD-FMK (TSZ) treatment regulates phenotype of NSCs. In detail, the proliferative capacity of NSCs was significantly decreased in the presence of continual TSZ treatment, and the transcription of proinflammatory genes was upregulated, while the transcription of neurotrophic factors was inhibited. NSCs exhibited an obvious tendency to differentiate into glial cells under short-duration TSZ stimulation (6 h and 12 h); as the stimulus duration increased (24 h), the differentiation ability of the NSCs was significantly inhibited. These phenotypic changes are not conducive to neural cell survival and neural repair. Moreover, we examined the effect of necroptosis inhibitors on TSZ-treated NSCs. Necrostatin-1 and necrosulfonamide significantly reduced the necroptosis of NSCs after TSZ treatment and improved the phenotypic function of NSCs under TSZ stimulation. In additional in vivo experiments, after 2 weeks of administration, the necroptosis inhibitors reduced the necroptosis of NSCs and improved functional recovery in SCI mice. Taken together, these data indicate that the inhibition of NSC necroptosis with necroptosis inhibitors facilitates survival and phenotype maintenance in vitro and contributes to neuroprotection and repair in vivo. Our findings suggest that blocking necroptosis of eNSCs may be a potential therapeutic strategy for treating SCI.

neurosciences
Differential role of SIRT1/MAPK pathway during cerebral ischemia in rats and humans

Sireesh Kumar Teertam,Phanithi Prakash Babu

DOI: https://doi.org/10.1038/s41598-021-85577-9

2021-03-18

Abstract:Cerebral ischemia (CI) is a severe cause of neurological dysfunction and mortality. Sirtuin-1 (Silent information regulator family protein 1, SIRT1), an oxidized nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylase, plays an important role in protection against several neurodegenerative disorders. The present study aims to investigate the protective role of SIRT1 after CI in experimental young and aged rats and humans. Also, the study examines the possible regulatory mechanisms of neuronal death in CI settings. Immunoblotting and immunohistochemistry were used to evaluate changes in the expression of SIRT1, JNK/ERK/MAPK/AKT signaling, and pro-apoptotic caspase-3 in experimental rats and CI patients. The study findings demonstrated that, in aged experimental rats, SIRT1 activation positively influenced JNK and ERK phosphorylation and modulated neuronal survival in AKT-dependent manner. Further, the protection conferred by SIRT1 was effectively reversed by JNK inhibition and increased pro-apoptotic caspase-3 expression. In young experimental rats, SIRT1 activation decreased the phosphorylation of stress-induced JNK, ERK, caspase-3, and increased the phosphorylation of AKT after CI. Inhibition of SIRT1 reversed the protective effect of resveratrol. More importantly, in human patients, SIRT1 expression, phosphorylation of JNK/ERK/MAPK/AKT signaling and caspase-3 were up-regulated. In conclusion, SIRT1 could possibly be involved in the modulation of JNK/ERK/MAPK/AKT signaling pathway in experimental rats and humans after CI.
Abstract TP32: Sirtuin 3 Regulation of Mitochondrial Dynamics and Neuronal Apoptosis During Ischemia/Reperfusion

Sanjana Chandran,Thomas H Sanderson

DOI: https://doi.org/10.1161/str.55.suppl_1.tp32

IF: 10.17

2024-02-01

Stroke

Abstract:Ischemic stroke occurs when the blood supply to the brain is interrupted, reducing the access of affected tissue to oxygen and glucose. The lack of oxygen inhibits the electron transport chain, leading to intracellular ATP deficiency, cellular damage, and death. The restoration of blood flow, known as reperfusion, allows the reintroduction of oxygen but may cause increased oxidative stress, as it hyperactivates the electron transport chain and thus induces excessive production of reactive oxygen species (ROS), leading to further cell death. One potential therapeutic target for reperfusion injury is Sirtuin 3 (SIRT3), which mediates the deacetylation of enzymes that are responsible for the reduction of ROS, leading to protection against oxidative stress. This study aims to understand the role of SIRT3 on ischemia and reperfusion-induced neuronal apoptosis. Primary neurons were isolated from wildtype mice postnatal day 0-1 and cultured for 14 days. The neurons underwent 2-hour oxygen-glucose deprivation mimicking stroke, followed by reperfusion. The neurons were then lysed, and western blots were done to analyze changes in protein levels. The western blots show that SIRT3 levels significantly decline over 1-6 hours post-reperfusion (n≥3, p<0.05), and TOM20, a mitochondrial protein, declines at 1 hour post-reperfusion(n≥3, p<0.05), indicating mitophagy. In addition, the cleavage of caspase-3 significantly increases at 4 hours post-reperfusion (n=3, p<0.05), implying apoptosis. Our data suggests that SIRT3 plays a crucial role in the mitochondrial metabolism of neurons and could be a potential target for reperfusion therapy. Future experiments would examine the effects of a SIRT3 activator and inhibitor on cell apoptosis.

peripheral vascular disease,clinical neurology
Sirtuin-1 - Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke

Deepaneeta Sarmah,Aishika Datta,Harpreet Kaur,Kiran Kalia,Anupom Borah,Anne Marie Rodriguez,Dileep R. Yavagal,Pallab Bhattacharya

DOI: https://doi.org/10.1007/s12015-021-10315-7

2022-02-01

Stem Cell Reviews and Reports

Abstract:AimStroke results in long term serious disability that affect millions across the globe. Several clinical and preclinical studies have reinforced the therapeutic use of stem cells in stroke patients to enhance their quality of life. Previous studies from our lab have demonstrated that 1*105 allogeneic bone marrow-derived mesenchymal stem cells (BM-MSCs) when given intraarterially (IA) render neuroprotection by modulating the expression of inflammasomes. Sirtuins are a class of important deacylases having a significant role in cellular functioning. Sirtuin-1 (SIRT-1) is an important enzyme essential for regulating cellular metabolism, which is reduced following an ischemic episode. The present study aims to unviel the role of MSCs in regulating the brain SIRT-1 levels following stroke and the involvement of SIRT-1 in regulating inflammasome signaling to reduce cellular apoptosis towards rendering neuroprotection.Materials and Methods6 h post-reversible middle cerebral artery occlusion (MCAo), ovariectomized Sprague Dawley (SD) rats were infused intraarterially with 1*105 MSCs. 24 h after MCAo animals were examined for functional and behavioral outcomes. Brains were collected for assessing size of infarct and neuronal morphology. Molecular and immunofluroscence studies were also performed for assessing changes in gene and protein expressions. Extent of apoptosis was also determined in different groups. Inhibition study with SIRT-1 specific inhibitor EX-527 was also performed.ResultsA reduction in infarct size and improvement in motor functional and behavioral outcomes following infusion of MSCs IA at 6 h post-stroke was observed. Increase in average neuronal density and neuronal length was also seen. Increased expression of SIRT-1, BDNF and concomitant reduction in the expression of different inflammatory and apoptotic markers in the brain cortical regions were observed following MSCs treatment.ConclusionOur study provides a preliminary evidence that post-stroke IA MSCs therapy regulates SIRT-1 to modulate NF-κB pathway to mitigate inflammasome signaling and cellular apoptosis. This study using IA approach for administering MSCs is highly relevant clinically. Our study is the first to report that neuroprotective effects of IA MSCs in rodent focal ischemia is mediated by SIRT-1 regulation of inflammasome signaling.Graphical abstract

cell biology,medicine, research & experimental,cell & tissue engineering
Neuronal RARβ Signaling Modulates PTEN Activity Directly in Neurons and via Exosome Transfer in Astrocytes to Prevent Glial Scar Formation and Induce Spinal Cord Regeneration

Maria B Goncalves,Tony Malmqvist,Earl Clarke,Chantal J Hubens,John Grist,Carl Hobbs,Diogo Trigo,Mårten Risling,Maria Angeria,Peter Damberg,Thomas P Carlstedt,Jonathan P T Corcoran

DOI: https://doi.org/10.1523/JNEUROSCI.1339-15.2015

2015-11-25

Abstract:Failure of axonal regeneration in the central nervous system (CNS) is mainly attributed to a lack of intrinsic neuronal growth programs and an inhibitory environment from a glial scar. Phosphatase and tensin homolog (PTEN) is a major negative regulator of neuronal regeneration and, as such, inhibiting its activity has been considered a therapeutic target for spinal cord (SC) injuries (SCIs). Using a novel model of rat cervical avulsion, we show that treatment with a retinoic acid receptor β (RARβ) agonist results in locomotor and sensory recovery. Axonal regeneration from the severed roots into the SC could be seen by biotinylated dextran amine labeling. Light micrographs of the dorsal root entry zone show the peripheral nervous system (PNS)-CNS transition of regrown axons. RARβ agonist treatment also resulted in the absence of scar formation. Mechanism studies revealed that, in RARβ-agonist-treated neurons, PTEN activity is decreased by cytoplasmic phosphorylation and increased secretion in exosomes. These are taken up by astrocytes, resulting in hampered proliferation and causing them to arrange in a normal-appearing scaffold around the regenerating axons. Attribution of the glial modulation to neuronal PTEN in exosomes was demonstrated by the use of an exosome inhibitor in vivo and PTEN siRNA in vitro assays. The dual effect of RARβ signaling, both neuronal and neuronal-glial, results in axonal regeneration into the SC after dorsal root neurotmesis. Targeting this pathway may open new avenues for the treatment of SCIs. Significance statement: Spinal cord injuries (SCIs) often result in permanent damage in the adult due to the very limited capacity of axonal regeneration. Intrinsic neuronal programs and the formation of a glial scar are the main obstacles. Here, we identify a single target, neuronal retinoic acid receptor β (RARβ), which modulates these two aspects of the postinjury physiological response. Activation of RARβ in the neuron inactivates phosphatase and tensin homolog and induces its transfer into the astrocytes in small vesicles, where it prevents scar formation. This may open new therapeutic avenues for SCIs.
Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKKβ promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice

Irini Papazian,Eleni Tsoukala,Athena Boutou,Maria Karamita,Konstantinos Kambas,Lida Iliopoulou,Roman Fischer,Roland E Kontermann,Maria C Denis,George Kollias,Hans Lassmann,Lesley Probert

DOI: https://doi.org/10.1186/s12974-021-02200-4

2021-09-26

Abstract:Background: During inflammatory demyelination, TNF receptor 1 (TNFR1) mediates detrimental proinflammatory effects of soluble TNF (solTNF), whereas TNFR2 mediates beneficial effects of transmembrane TNF (tmTNF) through oligodendroglia, microglia, and possibly other cell types. This model supports the use of selective inhibitors of solTNF/TNFR1 as anti-inflammatory drugs for central nervous system (CNS) diseases. A potential obstacle is the neuroprotective effect of solTNF pretreatment described in cultured neurons, but the relevance in vivo is unknown. Methods: To address this question, we generated mice with neuron-specific depletion of TNFR1, TNFR2, or inhibitor of NF-κB kinase subunit β (IKKβ), a main downstream mediator of TNFR signaling, and applied experimental models of inflammatory demyelination and acute and preconditioning glutamate excitotoxicity. We also investigated the molecular and cellular requirements of solTNF neuroprotection by generating astrocyte-neuron co-cultures with different combinations of wild-type (WT) and TNF and TNFR knockout cells and measuring N-methyl-D-aspartate (NMDA) excitotoxicity in vitro. Results: Neither neuronal TNFR1 nor TNFR2 protected mice during inflammatory demyelination. In fact, both neuronal TNFR1 and neuronal IKKβ promoted microglial responses and tissue injury, and TNFR1 was further required for oligodendrocyte loss and axonal damage in cuprizone-induced demyelination. In contrast, neuronal TNFR2 increased preconditioning protection in a kainic acid (KA) excitotoxicity model in mice and limited hippocampal neuron death. The protective effects of neuronal TNFR2 observed in vivo were further investigated in vitro. As previously described, pretreatment of astrocyte-neuron co-cultures with solTNF (and therefore TNFR1) protected them against NMDA excitotoxicity. However, protection was dependent on astrocyte, not neuronal TNFR1, on astrocyte tmTNF-neuronal TNFR2 interactions, and was reproduced by a TNFR2 agonist. Conclusions: These results demonstrate that neuronal TNF receptors perform fundamentally different roles in CNS pathology in vivo, with neuronal TNFR1 and IKKβ promoting microglial inflammation and neurotoxicity in demyelination, and neuronal TNFR2 mediating neuroprotection in excitotoxicity. They also reveal that previously described neuroprotective effects of solTNF against glutamate excitotoxicity in vitro are indirect and mediated via astrocyte tmTNF-neuron TNFR2 interactions. These results consolidate the concept that selective inhibition of solTNF/TNFR1 with maintenance of TNFR2 function would have combined anti-inflammatory and neuroprotective properties required for safe treatment of CNS diseases.
Neuroserpin Protects Rat Neurons And Microglia-Mediated Inflammatory Response Against Oxygen Glucose Deprivation- And Reoxygenation Treatments In An In Vitro Study

Xuelian Yang,Tetsuya Asakawa,Sha Han,Ling Liu,Wei Li,Weiwen Wu,Yunhe Luo,Wenjie Cao,Xin Cheng,Baoguo Xiao,Hiroki Namba,Chuanzhen Lu,Qiang Dong,Liang Wang

DOI: https://doi.org/10.1159/000443089

2016-01-01

Cellular Physiology and Biochemistry

Abstract:Background/Aims: Neuroserpin (NSP) is known for its neuroprotective role in cerebral ischemic animal models and patients. Our laboratory conducted a series of investigations on the neuroprotection of NSP in different cells in the brain. In the present study, we further observe the effects of NSP on neurons and microglia-mediated inflammatory response following oxygen-glucose deprivation (OGD), and explore possible mechanisms related to neuroprotection of OGD in the central nervous system (CNS). Methods: Neurons and microglia from neonatal rats were treated with OGD followed by reoxygenation (OGD/R). To confirm the effects of NSP, the neuronal survival, neuronal apoptosis, and lactate dehydrogenase (LDH) release were measured in cultured neurons. Furthermore, the levels of IL-1 beta and nitric oxide (NO) release were also detected in cultured microglia. The possible mechanisms for the neuroprotective effect of NSP were explored using Western blot analysis. Results: NSP administration can reverse abnormal variations in neurons and microgliamediated inflammatory response induced by OGD/R processes. The neuronal survival rate, neuronal apoptosis rate, and LDH release were significantly improved by NSP administration in neurons. Simultaneously, the release of IL-1 beta and NO were significantly reduced by NSPin microglia. Western blot showed that the expression of ERK, P38, and JNK was upregulated in microglia by the OGD/R treatment, and these effects were significantly inhibited by NSP. Conclusion: These data verified the neuroprotective effects of NSP on neurons and microglia-mediated inflammatory response. Inhibition of the mitogen-activated protein kinase (MAPK) signaling pathways might playa potential role in NSP neuroprotection on microglia-mediated inflammatory response, which needs further verification. Copyright (C) 2016 S. Karger AG, Basel
SIRT1 activation attenuates microglia-mediated synaptic engulfment in postoperative cognitive dysfunction

Yi Sun,Yuzhu Wang,Fan Ye,Victoria Cui,Dandan Lin,Hui Shi,Yan Zhang,Anshi Wu,Changwei Wei

DOI: https://doi.org/10.3389/fnagi.2022.943842

IF: 4.8

2022-11-11

Frontiers in Aging Neuroscience

Abstract:Background: Postoperative cognitive dysfunction (POCD) is a debilitating neurological complication in surgical patients. Current research has focused mainly on microglial activation, but less is known about the resultant neuronal synaptic changes. Recent studies have suggested that Sirtuin-1 (SIRT1) plays a critical role in several different neurological disorders via its involvement in microglial activation. In this study, we evaluate the effects of SIRT1 activation in a POCD mouse model. Materials and methods: Exploratory laparotomy was performed in mice aged 12–14 months under sevoflurane anesthesia to establish our animal POCD model. Transcriptional changes in the hippocampus after anesthesia and surgery were evaluated by RNA sequencing. SIRT1 expression was verified by Western Blot. Mice were treated with SIRT1 agonist SRT1720 or vehicle after surgery. Changes in microglia morphology, microglial phagocytosis, presence of dystrophic neurites, and dendritic spine density were evaluated. Cognitive performance was evaluated using the Y maze and Morris water maze (MWM). Results: Sirtuin-1 expression levels were downregulated in POCD. Exposure to anesthesia and surgery lead to alteration in microglia morphology, increased synaptic engulfment, dendritic spine loss, and cognitive deficits. These effects were alleviated by SRT1720 administration. Conclusion: This study suggests an important neuroprotective role for SIRT1 in POCD pathogenesis. Increasing SIRT1 function represents a promising therapeutic strategy for prevention and treatment of POCD.

neurosciences,geriatrics & gerontology,gerontology
Facing chronic illness: the family support model and its benefits.

Linda Boise,B. Heagerty,L. Eskenazi

DOI: https://doi.org/10.1016/0738-3991(95)00791-1

IF: 3.467

Patient Education and Counseling

Abstract:

[Ultrastructure of Rous sarcoma virus cultivated in vitro].

Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition

Detection of macroenzymes in serum by high-performance gel permeation chromatography.

SIRT1 Protects Against Apoptosis by Promoting Autophagy in the Oxygen Glucose Deprivation/Reperfusion-Induced Injury.

Modulation of Sirt1-mTORC1 Pathway in Microglia Attenuates Retinal Ganglion Cell Loss After Optic Nerve Injury

The Neuroprotective Effects of SIRT1 on NMDA-Induced Excitotoxicity

Chronically low NMNAT2 expression causes sub-lethal SARM1 activation and altered response to nicotinamide riboside in axons

[Type 1 neurofibromatosis in Tunisia: 66 cases].

Synthesis of racemic sirenin, a plant sex hormone.

Overexpression of Sirtuin 1 protein in neurons prevents and reverses experimental diabetic neuropathy.

Modulation by SIRT1-mTORC1 Pathway Microglia Pruning Retinal Ganglion Cell Dendrites

Oxygen–Glucose Deprivation/Reperfusion-Induced Sirt3 Reduction Facilitated Neuronal Injuries in an Apoptosis-Dependent Manner During Prolonged Reperfusion

Inhibition of Neural Stem Cell Necroptosis Mediated by RIPK1/MLKL Promotes Functional Recovery After SCI

Differential role of SIRT1/MAPK pathway during cerebral ischemia in rats and humans

Abstract TP32: Sirtuin 3 Regulation of Mitochondrial Dynamics and Neuronal Apoptosis During Ischemia/Reperfusion

Sirtuin-1 - Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke

Neuronal RARβ Signaling Modulates PTEN Activity Directly in Neurons and via Exosome Transfer in Astrocytes to Prevent Glial Scar Formation and Induce Spinal Cord Regeneration

Fundamentally different roles of neuronal TNF receptors in CNS pathology: TNFR1 and IKKβ promote microglial responses and tissue injury in demyelination while TNFR2 protects against excitotoxicity in mice

Neuroserpin Protects Rat Neurons And Microglia-Mediated Inflammatory Response Against Oxygen Glucose Deprivation- And Reoxygenation Treatments In An In Vitro Study

SIRT1 activation attenuates microglia-mediated synaptic engulfment in postoperative cognitive dysfunction

Facing chronic illness: the family support model and its benefits.